April 14, 2026 Partner Therapeutics announces submission of supplemental Biologics License Application (sBLA) to FDA for BIZENGRI® (zenocutuzumab-zbco) in NRG1 Fusion Positive Cholangiocarcinoma and Inclusion in updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
April 14, 2026 The Beautiful Game as Seen from My Angle Captures a Lifelong Passion for Soccer, Identity, and Global Connection
April 14, 2026 The First Jump Launches a Thrilling Sci-Fi Adventure of Survival, Power, and Galactic Conflict